Naviscan PET scanners performing positron emission mammography (PEM) have been installed in two European centers: Radiologie und Nuklearmedizin in Ludwigshafen, Germany, and Medica in Istanbul, Turkey.
Women diagnosed with breast cancer are increasingly burdened by multiple imaging appointments prior to surgery, according to researchers from Fox Chase Cancer Center in Philadelphia, who presented the findings Dec. 9 at the San Antonio Breast Cancer Symposium.
The National Institute of Cancer, a Mexican oncologic center, is the first in the country to offer positron emission mammography (PEM), which is a breast application of Naviscan's PET scanner that shows the location as well as the metabolic phase of a lesion.
More than half of women will receive at least one false-positive recall after 10 years of annual mammography screening, according to a study published Oct. 18 in the Annals of Internal Medicine. The findings may fan the flames of the screening debate as an accompanying editorial suggested that the results support screening intervals of two years or more. However, educating women about the incidence of false positives may reduce anxiety, according to the lead author.
Written by Lisa Fratt
California Gov. Edmund G. Brown Jr. has vetoed SB 791, which would have required mammography providers to notify women about their breast density and potential benefits of additional screening.
A nationwide U.S. survey found that women overwhelmingly want the option for additional screening tests to find cancer early, even when testing resulted in a false positive. Nine out of 10 women who required a biopsy to determine a false positive indicated that they would still opt for the additional screening the following year.
Centric Health has entered into an agreement to acquire Medical Imaging Centres and certain business assets of Rads 24/7 Teleradiology Consultants for up to $36.2 million.
Sectra has completed its mammography-modality deal with Royal Philips Electronics.
The global market for diagnostic imaging will exceed $24.4 billion by 2016 with a compound annual growth rate of 6 percent from 2009 to 2016, according to a report published by GBI Research.
Women with mammographically dense breasts not only face a higher risk of breast cancer, but their tumors also are more likely to have more aggressive characteristics than women with less dense breasts, according to a study published online July 27 in the Journal of the National Cancer Institute.
A federal district court has convicted 41-year-old Radiologist Rajashakher P. Reddy, MD, of more than 30 counts of fraud and obstruction of justice in connection with his signing tens of thousands of radiology reports that neither he nor any other physician actually viewed.
Payors and patients may be vastly overpaying for some of the most common CT, MRI and mammography exams owing to huge price disparities both within and across regions, according to a quarterly report issued by change:healthcare.
Northern California provider John Muir Health has opened the Theresa M. Caygill Breast Health Center, which will offer patient screening, treatment, education and other services.
Saint Joseph Regional Medical Center of Mishawaka, Ind., has purchased XRC Medical Imaging in South Bend, Ind., through an agreement with X-Ray Consultants.
In its first annual "Breast Cancer Deadline 2020 Progress Report," the National Breast Cancer Coalition cited minimal progress toward ending the disease. To achieve its goal of ending breast cancer by Jan. 1, 2020, the organization advocates a two-pronged approach to research: determining the causes of and methods to prevent breast cancer metastasis and preventing breast cancer from developing in the first place.
Interval breast cancers were larger, of more advanced stages, more poorly differentiated, more likely to have lymph node involvement and had a higher proliferation rate compared with matched screen-detected cancers, according to a study published in the May issue of the Journal of the National Cancer Institute, leading the authors to call for more sensitive screening modalities and different approaches for early detection of fast-growing tumors.
Written by James Brice
A new day is dawning for breast cancer diagnosis, treatment and monitoring with the help of molecular imaging.
The American Journal of Roentgenology has published two separate studies this month demonstrating the clinical acceptance of Naviscan’s Positron Emission Mammography (PEM) scanner. The first study concluded that breast radiologists can achieve a high level of diagnostic performance in interpreting PEM images after a two-hour tutorial. The second study established a standard lexicon for the evaluation of PEM images.
Written by Lisa Fratt
The volume of advanced imaging services delivered to Medicare beneficiaries decreased in 2009 for the first time in 11 years, potentially signaling the end of the era of rapid growth in medical imaging volume, according to a study conducted by The Moran Company. The dip in volume could spell reduced access to advanced imaging and may drive healthcare costs higher.
|
RSS 
